DOCK2 and colorectal neoplasm: Studies have shown that genetic mutations in IKZF1 are associated with poor prognosis in hematologic tumors and colorectal tumors (39–41); Low expression of DOCK2 is associated with a poor prognosis in colorectal cancer and lung cancer patients (42–44).